Efg Asset Management (Americas) Corp. Abb Vie Inc. Transaction History

Efg Asset Management (Americas) Corp.

$508 Million
Q3 2024

A detailed history of Efg Asset Management (Americas) Corp. transactions in Abb Vie Inc. stock. As of the latest transaction made, Efg Asset Management (Americas) Corp. holds 10,195 shares of ABBV stock, worth $1.87 Million. This represents 0.4% of its overall portfolio holdings.

Number of Shares

10,195

Previous 10,784 5.46%

Holding current value

$1.87 Million

Previous $1.85 Million 8.87%

% of portfolio

0.4%

Previous 0.36%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	SELL	$163.84 - $199.33 $96,501 - $117,405	-589 Reduced 5.46%	10,195 $2.01 Million
Q2 2024 Aug 06, 2024	BUY	$154.79 - $180.76 $430,780 - $503,055	2,783 Added 34.78%	10,784 $1.85 Million
Q1 2024 Apr 22, 2024	SELL	$159.82 - $182.1 $319,799 - $364,382	-2,001 Reduced 20.01%	8,001 $1.46 Million
Q4 2023 Feb 01, 2024	SELL	$137.6 - $154.97 $4,265 - $4,804	-31 Reduced 0.31%	10,002 $1.55 Million
Q3 2023 Nov 09, 2023	SELL	$133.59 - $154.65 $26,450 - $30,620	-198 Reduced 1.94%	10,033 $1.5 Million
Q2 2023 Aug 29, 2023	BUY	$132.51 - $164.9 $355,524 - $442,426	2,683 Added 35.55%	10,231 $1.38 Million
Q1 2023 May 04, 2023	BUY	$144.61 - $166.54 $76,354 - $87,933	528 Added 7.52%	7,548 $1.2 Million
Q4 2022 Feb 09, 2023	BUY	$138.31 - $165.87 $51,313 - $61,537	371 Added 5.58%	7,020 $1.14 Million
Q3 2022 Nov 07, 2022	SELL	$134.21 - $153.93 $31,539 - $36,173	-235 Reduced 3.41%	6,649 $892,000
Q2 2022 Jul 13, 2022	BUY	$137.62 - $174.96 $140,922 - $179,159	1,024 Added 17.47%	6,884 $1.05 Million
Q1 2022 May 05, 2022	SELL	$131.98 - $163.75 $3,035 - $3,766	-23 Reduced 0.39%	5,860 $950,000
Q4 2021 Jan 24, 2022	SELL	$107.43 - $135.93 $83,150 - $105,209	-774 Reduced 11.63%	5,883 $797,000
Q3 2021 Oct 22, 2021	BUY	$106.4 - $120.78 $31,600 - $35,871	297 Added 4.67%	6,657 $718,000
Q2 2021 Jul 23, 2021	BUY	$105.21 - $117.21 $26,933 - $30,005	256 Added 4.19%	6,360 $716,000
Q1 2021 Apr 09, 2021	BUY	$102.3 - $112.62 $624,439 - $687,432	6,104 New	6,104 $661,000

Others Institutions Holding ABBV

# of Institutions

3,849

Shares Held

1.25B

Call Options Held

16.8M

Put Options Held

12.2M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $324B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Efg Asset Management (Americas) Corp., based on Form 13F filings with the SEC.

News

Stay updated on Efg Asset Management (Americas) Corp. with notifications on news.

Account

Efg Asset Management (Americas) Corp. Abb Vie Inc. Transaction History